155 related articles for article (PubMed ID: 9067469)
1. Role of dopamine D1- and NMDA receptors in regulating neurotensin release in the striatum and nucleus accumbens.
Wagstaff JD; Gibb JW; Hanson GR
Brain Res; 1997 Feb; 748(1-2):241-4. PubMed ID: 9067469
[TBL] [Abstract][Full Text] [Related]
2. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
Singh NA; Bush LG; Gibb JW; Hanson GR
Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780
[TBL] [Abstract][Full Text] [Related]
3. Dopamine-mediated changes in central nervous system neurotensin systems: a role for NMDA receptors.
Singh NA; Bush LG; Gibb JW; Hanson GR
Eur J Pharmacol; 1990 Oct; 187(3):337-44. PubMed ID: 2150044
[TBL] [Abstract][Full Text] [Related]
4. Systemic morphine-induced Fos protein in the rat striatum and nucleus accumbens is regulated by mu opioid receptors in the substantia nigra and ventral tegmental area.
Bontempi B; Sharp FR
J Neurosci; 1997 Nov; 17(21):8596-612. PubMed ID: 9334431
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D1- and D2-dependent catalepsy in the rat requires functional NMDA receptors in the corpus striatum, nucleus accumbens and substantia nigra pars reticulata.
Ozer H; Ekinci AC; Starr MS
Brain Res; 1997 Nov; 777(1-2):51-9. PubMed ID: 9449412
[TBL] [Abstract][Full Text] [Related]
6. D1 dopamine receptor-mediated induction of zif268 and c-fos in the dopamine-depleted striatum: differential regulation and independence from NMDA receptors.
Keefe KA; Gerfen CR
J Comp Neurol; 1996 Apr; 367(2):165-76. PubMed ID: 8708002
[TBL] [Abstract][Full Text] [Related]
7. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
Huang KX; Bergstrom DA; Ruskin DN; Walters JR
Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
[TBL] [Abstract][Full Text] [Related]
8. Role of the parafascicular thalamic nucleus and N-methyl-D-aspartate transmission in the D1-dependent control of in vivo acetylcholine release in rat striatum.
Consolo S; Baronio P; Guidi G; Di Chiara G
Neuroscience; 1996 Mar; 71(1):157-65. PubMed ID: 8834399
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of glutamate, aspartate and gamma-amino-butyrate release by N-methyl-D-aspartate receptors in rat striatum after partial and extensive lesions to the nigro-striatal dopamine pathway.
Abarca J; Bustos G
Neurochem Int; 1999 Jul; 35(1):19-33. PubMed ID: 10403427
[TBL] [Abstract][Full Text] [Related]
10. Glutamatergic regulation of haloperidol-induced c-fos expression in the rat striatum and nucleus accumbens.
Hussain N; Flumerfelt BA; Rajakumar N
Neuroscience; 2001; 102(2):391-9. PubMed ID: 11166125
[TBL] [Abstract][Full Text] [Related]
11. Effects of NMDA receptor antagonists on D1 dopamine receptor-mediated changes in striatal immediate early gene expression: evidence for involvement of pharmacologically distinct NMDA receptors?
Keefe KA; Ganguly A
Dev Neurosci; 1998; 20(2-3):216-28. PubMed ID: 9691195
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of dopamine release by N-methyl-D-aspartate receptors in rat striatum after partial and extreme lesions of the nigro-striatal pathway.
Andrés ME; Gysling K; Bustos G
Brain Res; 1998 Jun; 797(2):255-66. PubMed ID: 9666143
[TBL] [Abstract][Full Text] [Related]
13. Role of NR2B-containing N-methyl-D-aspartate receptors in haloperidol-induced c-Fos expression in the striatum and nucleus accumbens.
Lee J; Rajakumar N
Neuroscience; 2003; 122(3):739-45. PubMed ID: 14622917
[TBL] [Abstract][Full Text] [Related]
14. Mediation of glutamatergic receptors and nitric oxide on striatal dopamine release evoked by anatoxin-a. An in vivo microdialysis study.
Campos F; Alfonso M; Vidal L; Faro LR; Durán R
Eur J Pharmacol; 2006 Oct; 548(1-3):90-8. PubMed ID: 16963020
[TBL] [Abstract][Full Text] [Related]
15. Dizocilpine (MK-801) and tetrodotoxin influence accumbal dopamine release evoked by intrapallidal morphine.
Anagnostakis Y; Kastellakis A; Spyraki C
Eur Neuropsychopharmacol; 1998 Feb; 8(1):47-53. PubMed ID: 9452940
[TBL] [Abstract][Full Text] [Related]
16. Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens.
Wagstaff JD; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1996 Aug; 278(2):547-54. PubMed ID: 8768703
[TBL] [Abstract][Full Text] [Related]
17. The role of NMDA receptor systems in neuropeptide responses to stimulants of abuse.
Hanson GR; Singh N; Merchant K; Johnson M; Gibb JW
Drug Alcohol Depend; 1995 Feb; 37(2):107-10. PubMed ID: 7758400
[TBL] [Abstract][Full Text] [Related]
18. NMDA receptor blockade attenuates locomotion elicited by intrastriatal dopamine D1-receptor stimulation.
Kreipke CW; Walker PD
Synapse; 2004 Jul; 53(1):28-35. PubMed ID: 15150738
[TBL] [Abstract][Full Text] [Related]
19. Food restriction increases NMDA receptor-mediated calcium-calmodulin kinase II and NMDA receptor/extracellular signal-regulated kinase 1/2-mediated cyclic amp response element-binding protein phosphorylation in nucleus accumbens upon D-1 dopamine receptor stimulation in rats.
Haberny SL; Carr KD
Neuroscience; 2005; 132(4):1035-43. PubMed ID: 15857708
[TBL] [Abstract][Full Text] [Related]
20. NMDA receptor antagonism modifies the synergistic regulation of striatal tachykinin gene expression induced by dopamine D(1) and serotonin(2) receptor stimulation following neonatal dopamine depletion.
Campbell BM; Walker PD
Brain Res Mol Brain Res; 2001 Sep; 93(1):90-4. PubMed ID: 11532342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
